The existence of a dedicated Chemistry Core has a number of benefits to each research project, particularly where development and optimization of chemical techniques is not the primary research focus. As a whole, the Core also provides many functions that are equally important to each Project (e.g. syntheses, radioisotope handling, consultation, robotic equipment, training) but can provide it much more efficiently than each Project by itself. Centralization of personnel, resources and supplies will help to reduce the cost of the proposed research and result in a more efficient operation. Another important function of the Core is to provide compounds for research that have been 1) rigorously tested and conform the standards, are synthesized under identical, reproducible conditions in technically adequate ways, 2) analyzed according to a standard protocol prior to use, and 3) synthesized in sufficient amounts so that they are available to all Project researchers. Finally, the Core will also conduct its own research, as it has in the past, to further improve synthesis and design of chelates, reporters, dyes and drug carriers. This is possible by the experienced staff members of this Core and their expertise in different areas of chemistry including bioconjugation, chelate design, peptide synthesis, organic synthesis, protein chemistry and isolation, magnetic particle synthesis and analytical chemistry. The Core Directors have a proven track record of active productive collaborations with investigators across multiple institutions, particularly the Pi's of this P50. The attendance of the key core personnel in our inter-group meetings insures that the PSO's imaging needs are met and that cutting-edge technologies are appropriately exploited in a timely and accurate manner.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA086355-11
Application #
8136698
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2010-09-01
Budget End
2011-08-31
Support Year
11
Fiscal Year
2010
Total Cost
$167,738
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Dubach, J Matthew; Kim, Eunha; Yang, Katherine et al. (2017) Quantitating drug-target engagement in single cells in vitro and in vivo. Nat Chem Biol 13:168-173
Vinegoni, Claudio; Fumene Feruglio, Paolo; Brand, Christian et al. (2017) Measurement of drug-target engagement in live cells by two-photon fluorescence anisotropy imaging. Nat Protoc 12:1472-1497
Iaconelli, Jonathan; Lalonde, Jasmin; Watmuff, Bradley et al. (2017) Lysine Deacetylation by HDAC6 Regulates the Kinase Activity of AKT in Human Neural Progenitor Cells. ACS Chem Biol 12:2139-2148
Arlauckas, Sean P; Garris, Christopher S; Kohler, Rainer H et al. (2017) In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy. Sci Transl Med 9:
Miller, Miles A; Weissleder, Ralph (2017) Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior. Adv Drug Deliv Rev 113:61-86
Engblom, Camilla; Pfirschke, Christina; Zilionis, Rapolas et al. (2017) Osteoblasts remotely supply lung tumors with cancer-promoting SiglecFhigh neutrophils. Science 358:
Miller, Miles A; Askevold, Bjorn; Mikula, Hannes et al. (2017) Nano-palladium is a cellular catalyst for in vivo chemistry. Nat Commun 8:15906
Roy, Jeremy; Kim, Bongki; Hill, Eric et al. (2016) Tyrosine kinase-mediated axial motility of basal cells revealed by intravital imaging. Nat Commun 7:10666
Pfirschke, Christina; Engblom, Camilla; Rickelt, Steffen et al. (2016) Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy. Immunity 44:343-54
Wu, Juwell W; Turcotte, Raphaƫl; Alt, Clemens et al. (2016) Defining Clonal Color in Fluorescent Multi-Clonal Tracking. Sci Rep 6:24303

Showing the most recent 10 out of 316 publications